Idexx Laboratories (IDXX) Retained Earnings (2009 - 2026)
Idexx Laboratories (IDXX) posted Retained Earnings of $7.0 billion for Q2 2026, up 5.07% on a QoQ basis from $6.7 billion in Q1 2026, and up 19.42% year-over-year from $5.9 billion in Q2 2025.
Analysis
Idexx Laboratories (IDXX) Retained Earnings (2009 - 2026) Analysis & Trends
Idexx Laboratories has reported Retained Earnings for 18 years, with the latest figure at $7.0 billion in Q2 2026.
- On a quarterly basis, Retained Earnings rose 19.42% year-over-year to $7.0 billion in Q2 2026; TTM through Jun 2026 was $7.0 billion, a 19.42% increase from a year earlier, with the FY2025 full-year figure at $6.4 billion, up 19.87% from the prior year.
- Retained Earnings was $7.0 billion for Q2 2026 at Idexx Laboratories, up from $6.7 billion in the prior quarter.
- The five-year high for Retained Earnings was $7.0 billion in Q2 2026, with the low at $3.1 billion in Q1 2022.
- Average Retained Earnings over 5 years is $4.9 billion, with a median of $4.8 billion recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings soared 30.87% in 2022, then gained 19.12% in 2025.
- Over 5 years, Retained Earnings stood at $3.6 billion in 2022, then rose by 23.48% to $4.4 billion in 2023, then advanced by 19.98% to $5.3 billion in 2024, then rose by 19.87% to $6.4 billion in 2025, then gained by 9.65% to $7.0 billion in 2026.
- The last three Retained Earnings figures came in at $7.0 billion (Q2 2026), $6.7 billion (Q1 2026), and $6.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 7.01 Bn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 14.65 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 8.88 Bn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 352.96 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | -11.43 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | -3.05 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 2.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.01 Bn |
| Mar 31, 2026 | 6.67 Bn |
| Dec 31, 2025 | 6.39 Bn |
| Sep 30, 2025 | 6.14 Bn |
| Jun 30, 2025 | 5.87 Bn |
| Mar 31, 2025 | 5.58 Bn |
| Dec 31, 2024 | 5.33 Bn |
| Sep 30, 2024 | 5.12 Bn |
| Jun 30, 2024 | 4.88 Bn |
| Mar 31, 2024 | 4.68 Bn |
| Dec 31, 2023 | 4.44 Bn |
| Sep 30, 2023 | 4.25 Bn |
| Jun 30, 2023 | 4.04 Bn |
| Mar 31, 2023 | 3.81 Bn |
| Dec 31, 2022 | 3.60 Bn |
| Sep 30, 2022 | 3.43 Bn |
| Jun 30, 2022 | 3.25 Bn |
| Mar 31, 2022 | 3.11 Bn |
| Dec 31, 2021 | 2.92 Bn |
| Sep 30, 2021 | 2.76 Bn |